Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1Breast 1

Conditions

Neoplasms 5Splenomegaly 2Leukemia 2Fatigue 2Anemia, Sickle Cell 2Anemia 2Weight Loss 1Venous Thromboembolism 1Thrombocytopenia 1Smoking Cessation 1Smoking 1Primary Myelofibrosis 1Plexosarcoma 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphocytosis 1Lymphadenopathy 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Gastrointestinal Stromal Tumors 1Fever 1Febrile Neutropenia 1Fanconi Anemia, Complementation Group D1 1Cancer-related Venous Thromboembolism 1Breast Neoplasms 1Anemia, Iron-Deficiency 1Anemia, Aplastic 1

Interventions

ofatumumab 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Metformin 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphadenopathy × Surveys and Questionnaires × Classical hematology × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡